Supernova Bioscience & Formulations Private Limited
About Supernova Bioscience & Formulations Private Limited
Data last updated:
Supernova Bioscience & Formulations Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 February 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24239UP2022PTC159832.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Rashi Mittal and Vivek Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at W/O Vivek Bansal Ram Nagar Court Road, Saharanpur, Uttar Pradesh, India – 247001.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressW/O Vivek Bansal Ram Nagar Court Road, Saharanpur, Uttar Pradesh, India – 247001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Supernova Bioscience & Formulations Private Limited FY 2025 filings available
Financial Statement Summary of Supernova Bioscience & Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Supernova Bioscience & Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Supernova Bioscience & Formulations are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Supernova Bioscience & Formulations Private Limited
Supernova Bioscience & Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashi Mittal | Director | 21 Feb 2022 | 4 Years 7 Months | Current |
| Vivek Bansal | Director | 21 Feb 2022 | 4 Years 7 Months | Current |
| Shaloo Bansal | Director | 11 Oct 2024 | 1 Years 11 Months | Current |
Charges & Borrowings of Supernova Bioscience & Formulations Private Limited
Supernova Bioscience & Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Supernova Bioscience & Formulations Private Limited
Employment history and EPFO contributions of people linked to Supernova Bioscience & Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Supernova Bioscience & Formulations Private Limited
Supernova Bioscience & Formulations Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Shaloo Bansal was appointed as Director on 11 Oct 2024.
Credit Ratings, Litigation & Regulatory Alerts for Supernova Bioscience & Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Supernova Bioscience & Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Supernova Bioscience & Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Supernova Bioscience & Formulations Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Supernova Bioscience & Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supernova Bioscience & Formulations Private Limited
Supernova Bioscience & Formulations is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 February 2022 (4+ years old) and is registered under CIN U24239UP2022PTC159832.
Supernova Bioscience & Formulations has 3 current directors:
- Rashi Mittal - Director
- Vivek Bansal - Director
- Shaloo Bansal - Director
The CIN (Corporate Identification Number) of Supernova Bioscience & Formulations is U24239UP2022PTC159832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supernova Bioscience & Formulations was incorporated on 21 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Shaloo Bansal was appointed as Director on 11 Oct 2024. Yash Garg ceased to be Director on 04 Oct 2024. Rashi Mittal was appointed as Director on 21 Feb 2022. Supernova Bioscience & Formulations has 4 board changes on record in total.
Yes, Supernova Bioscience & Formulations is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Supernova Bioscience & Formulations is at WO Vivek Bansal Ram Nagar Court Road, Saharanpur, Uttar Pradesh, India – 247001.
Supernova Bioscience & Formulations has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh.
Supernova Bioscience & Formulations operates in the chemicals industry, in the manufacturing segment.
No. Supernova Bioscience & Formulations is not listed on any stock exchange. It is an unlisted company.